Stock Analiz

Prime Medicine, Inc. (PRME) stock forecast and price target

Price $4.27 · data as of November 13, 2026

12-month price target

Average target$7.03
Upside / downside+64.5%
Analysts10
ConsensusBuy
Low $4.25Average $7.03High $9.00

Gold marker: average target · white marker: today’s price ($4.27)

Analyst ratings

Strong buy 1Buy 9Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.91+32.5%$8M
Next fiscal year
ends December 31, 2027
$-0.83+9.2%$11M
Next quarter
ends December 31, 2026
$-0.21+11.1%$6M
Quarter after
ends March 31, 2027
$-0.23+18.5%$1M

Consensus of the analysts covering Prime Medicine, updated daily. In the last 30 days 7 estimates were raised and 3 lowered.

Frequently asked questions

What is the Prime Medicine stock price target?

The average 12-month target from 10 analysts is $7.03, 64.5% above the current price of $4.27 Targets range from $4.25 to $9.00.

Is Prime Medicine a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 9 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Prime Medicine expected to earn?

Analysts expect EPS of $-0.91 for the fiscal year ending December 31, 2026 and $-0.83 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.